Filing Details

Accession Number:
0001576427-22-000130
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 16:16:09
Reporting Period:
2022-12-14
Accepted Time:
2022-12-15 16:16:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576427 Criteo S.a. CRTO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193080 James Warner C/O Criteo Legal Dept.
387 Park Avenue South, 12Th Floor
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-12-14 20,400 $10.29 47,953 No 4 M Direct
Ordinary Shares Disposition 2022-12-14 20,400 $25.90 27,553 No 4 S Direct
Ordinary Shares Acquisiton 2022-12-14 10,200 $10.29 37,753 No 4 M Direct
Ordinary Shares Disposition 2022-12-14 10,200 $25.90 27,553 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-employee Warrant (right to buy) Disposition 2022-12-14 20,400 $0.00 20,400 $10.29
Ordinary Shares Non-employee Warrant (right to buy) Disposition 2022-12-14 10,200 $0.00 10,200 $10.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-02-07 No 4 M Direct
0 2023-03-06 No 4 M Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).
  3. For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
  4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.
  6. Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.